Zevra Therapeutics Files Proxy Materials
Ticker: ZVRA · Form: DEFA14A · Filed: May 21, 2025 · CIK: 1434647
| Field | Detail |
|---|---|
| Company | Zevra Therapeutics, Inc. (ZVRA) |
| Form Type | DEFA14A |
| Filed Date | May 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, regulatory
TL;DR
Zevra Therapeutics (fka KemPharm) filed proxy docs, no fee. Standard stuff.
AI Summary
Zevra Therapeutics, Inc. (formerly KemPharm, Inc.) filed a Definitive Additional Materials (DEFA14A) on May 21, 2025. The filing relates to the company's proxy statement and indicates no fee was required for this filing. Zevra Therapeutics is incorporated in Delaware and operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing is a routine regulatory submission for Zevra Therapeutics, providing shareholders with information related to their proxy voting rights and corporate governance.
Risk Assessment
Risk Level: low — This filing is a standard DEFA14A, indicating routine corporate communication rather than a significant event like an acquisition or financial distress.
Key Players & Entities
- ZEVRA THERAPEUTICS, INC. (company) — Registrant
- KEMPHARM, INC (company) — Former company name
- 0001193125-25-123973 (filing_id) — Accession Number
- 20250521 (date) — Filing Date
FAQ
What is the purpose of a DEFA14A filing?
A DEFA14A filing, or Definitive Additional Materials, is used to provide additional information to shareholders related to a proxy statement, often after the initial filing.
What was Zevra Therapeutics' former name?
Zevra Therapeutics, Inc. was formerly known as KEMPHARM, INC.
On what date was this DEFA14A filing made?
This DEFA14A filing was made on May 21, 2025.
What is Zevra Therapeutics' Standard Industrial Classification (SIC) code?
Zevra Therapeutics' SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Was there a filing fee associated with this DEFA14A filing?
According to the filing, no fee was required for this DEFA14A filing.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 21, 2025 regarding ZEVRA THERAPEUTICS, INC. (ZVRA).